Therapeutic potential of tolerogenic dendritic cells in IBD: From animal models to clinical application

Clinical and Developmental Immunology

Volumn 2013, Issue , 2013, Pages

  Cabezón, Raquel ^a   Benítez Ribas, Daniel ^b  

^a HOSPITAL CLÍNIC   (Spain)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CD16 ANTIGEN; CD34 ANTIGEN; COLECALCIFEROL; DEXAMETHASONE; GRANULOCYTE COLONY STIMULATING FACTOR; INTERLEUKIN 10; KYNURENINE; VASOACTIVE INTESTINAL POLYPEPTIDE; ANTIGEN;

ANTIGEN EXPRESSION; ANTIGEN PRESENTATION; ANTIGEN PRESENTING CELL; APOPTOSIS; COLITIS; CROHN DISEASE; DENDRITIC CELL; ENTERITIS; HUMAN; IMMUNE RESPONSE; IMMUNOLOGICAL TOLERANCE; IMMUNOREGULATION; INTESTINE MUCOSA; LYMPHOCYTE PROLIFERATION; NONHUMAN; PLASMACYTOID DENDRITIC CELL; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; REVIEW; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; TH1 CELL; TH17 CELL; ANIMAL; DISEASE MODEL; IMMUNOLOGY; IMMUNOTHERAPY; INFLAMMATORY BOWEL DISEASE; METABOLISM; PHENOTYPE;

ANIMALS; ANTIGENS; CROHN DISEASE; DENDRITIC CELLS; DISEASE MODELS, ANIMAL; HUMANS; IMMUNE TOLERANCE; IMMUNOTHERAPY; INFLAMMATORY BOWEL DISEASES; PHENOTYPE;

EID: 84890011481     PISSN: 17402522     EISSN: 17402530     Source Type: Journal    
DOI: 10.1155/2013/789814     Document Type: Review

References (47)

1. Hart A. L., Al-Hassi H. O., Rigby R. J., Bell S. J., Emmanuel A. V., Knight S. C., Kamm M. A., Stagg A. J., Characteristics of intestinal dendritic cells in inflammatory bowel diseases. Gastroenterology 2005 129 1 50 65 2-s2.0-22344448660 10.1053/j.gastro.2005.05.013 (Pubitemid 41002042)
2. Coombes J. L., Powrie F., Dendritic cells in intestinal immune regulation. Nature Reviews Immunology 2008 8 6 435 446 2-s2.0-44349167059 10.1038/nri2335 (Pubitemid 351733420)
3. Figdor C. G., de Vries I. J., Lesterhuis W. J., Melief C. J., Dendritic cell immunotherapy: mapping the way. Nature Medicine 2004 10 5 475 480 2-s2.0-2442647551 10.1038/nm1039 (Pubitemid 38667904)
4. Steinman R. M., Banchereau J., Taking dendritic cells into medicine. Nature 2007 449 7161 419 426 2-s2.0-34848837386 10.1038/nature06175 (Pubitemid 47509552)
5. Giannoukakis N., Phillips B., Finegold D., Harnaha J., Trucco M., Phase I (safety) study of autologous tolerogenic dendritic cells in type 1 diabetic patients. Diabetes Care 2011 34 9 2026 2032
6. Hilkens C. M., Isaacs J. D., Tolerogenic dendritic cell therapy for rheumatoid arthritis: where are we now? Clinical & Experimental Immunology 2013 172 148 157
7. Piemonti L., Monti P., Allavena P., Sironi M., Soldini L., Leone B. E., Socci C., Di Carlo V., Glucocorticoids affect human dendritic cell differentiation and maturation. Journal of Immunology 1999 162 11 6473 6481 2-s2.0-0033152003 (Pubitemid 29309369)
8. Rozkova D., Horvath R., Bartunkova J., Spisek R., Glucocorticoids severely impair differentiation and antigen presenting function of dendritic cells despite upregulation of Toll-like receptors. Clinical Immunology 2006 120 3 260 271 2-s2.0-33746847266 10.1016/j.clim.2006.04.567 (Pubitemid 44175897)
9. + regulatory T cells by mycophenolic acid-treated dendritic cells. Journal of Leukocyte Biology 2008 84 4 1057 1064 2-s2.0-54249160146 10.1189/jlb.1007716
10. Penna G., Adorini L., 1 α25-dihydroxyvitamin D3 inhibits differentiation, maturation, activation, and survival of dendritic cells leading to impaired alloreactive T cell activation. Journal of Immunology 2000 164 5 2405 2411 2-s2.0-0034161714 (Pubitemid 30115468)
11. Naranjo-Gómez M., Raïch-Regué D., Oñate C., Grau-López L., Ramo-Tello C., Pujol-Borrell R., Martínez- Cáceres E., Borràs F. E., Comparative study of clinical grade human tolerogenic dendritic cells. Journal of Translational Medicine 2011 9 89 2-s2.0-84855722632
12. Pedersen A. E., Schmidt E. G., Gad M., Poulsen S. S., Claesson M. H., Dexamethasone/1 α -25-dihydroxyvitamin D3-treated dendritic cells suppress colitis in the SCID T-cell transfer model. Immunology 2009 127 3 354 364 2-s2.0-66549100149 10.1111/j.1365-2567.2008.02996.x
13. Boks M. A., Kager-Groenland J. R., Haasjes M. S., Zwaginga J. J., van Ham S. M., ten Brinke A., IL-10-generated tolerogenic dendritic cells are optimal for functional regulatory T cell induction-a comparative study of human clinical-applicable DC. Clinical Immunology 2012 142 3 332 342 2-s2.0-84857370127 10.1016/j.clim.2011.11.011
14. Collin M., McGovern N., Haniffa M., Human dendritic cell subsets. Immunology 2013 140 1 22 30 10.1111/imm.12117
15. Mann E. R., Landy J. D., Bernardo D., Peake S. T., Hart A. L., Al-Hassi H. O., Knight S. C., Intestinal dendritic cells: their role in intestinal inflammation, manipulation by the gut microbiota and differences between mice and men. Immunology Letters 2013 150 30 40
16. + regulatory T cells via a TGF- β -and retinoic acid-dependent mechanism. Journal of Experimental Medicine 2007 204 8 1757 1764 2-s2.0-34547788180 10.1084/jem.20070590 (Pubitemid 47236314)
17. Sun C. M., Hall J. A., Blank R. B., Bouladoux N., Oukka M., Mora J. R., Belkaid Y., Small intestine lamina propria dendritic cells promote de novo generation of Foxp3 T reg cells via retinoic acid. Journal of Experimental Medicine 2007 204 8 1775 1785 2-s2.0-34547757390 10.1084/jem.20070602 (Pubitemid 47236316)
18. + dendritic cells express indoleamine 2,3-dioxygenase which influences T regulatory/T effector cell balance and oral tolerance induction. Gut 2010 59 5 595 604 2-s2.0-77951737056 10.1136/gut.2009.185108
19. Mahnke K., Schmitt E., Bonifaz L., Enk A. H., Jonuleit H., Immature, but not inactive: the tolerogenic function of immature dendritic cells. Immunology and Cell Biology 2002 80 5 477 483 2-s2.0-0036378101 10.1046/j.1440-1711.2002. 01115.x
20. Cools N., Ponsaerts P., van Tendeloo V. F., Berneman Z. N., Balancing between immunity and tolerance: an interplay between dendritic cells, regulatory T cells, and effector T cells. Journal of Leukocyte Biology 2007 82 6 1365 1374 2-s2.0-35549004528 10.1189/jlb.0307166 (Pubitemid 350276946)
21. Rutella S., Locatelli F., Intestinal dendritic cells in the pathogenesis of inflammatory bowel disease. World Journal of Gastroenterology 2011 17 33 3761 3775 2-s2.0-80053911536 10.3748/wjg.v17.i33.3761
22. Perona-Wright G., Anderton S. M., Howie S. E., Gray D., IL-10 permits transient activation of dendritic cells to tolerize T cells and protect from central nervous system autoimmune disease. International Immunology 2007 19 9 1123 1134 2-s2.0-34548808554 10.1093/intimm/dxm084 (Pubitemid 47434245)
23. + T cell anergy by peripheral blood DC2 precursors. European Journal of Immunology 2001 31 2547 2557 (Pubitemid 32898721)
24. Allavena P., Piemonti L., Longoni D., Bernasconi S., Stoppacciaro A., Ruco L., Mantovani A., IL-10 prevents the differentiation of monocytes to dendritic cells but promotes their maturation to macrophages. European Journal of Immunology 1998 28 359 369 (Pubitemid 28048306)
25. Glocker E. O., Kotlarz D., Boztug K., Gertz E. M., Schäffer A. A., Noyan F., Perro M., Diestelhorst J., Allroth A., Murugan D., Hätscher N., Pfeifer D., Sykora K.-W., Sauer M., Kreipe H., Lacher M., Nustede R., Woellner C., Baumann U., Salzer U., Koletzko S., Shah N., Segal A. W., Sauerbrey A., Buderus S., Snapper S. B., Grimbacher B., Klein C., Inflammatory bowel disease and mutations affecting the interleukin-10 receptor. The New England Journal of Medicine 2009 361 21 2033 2045 2-s2.0-70949087383 10.1056/NEJMoa0907206
26. + T cells in an interleukin-10-dependent manner. Immunity 2011 34 4 554 565 2-s2.0-79954620910 10.1016/j.immuni.2011.01.020
27. Matta B. M., Castellaneta A., Thomson A. W., Tolerogenic plasmacytoid DC. European Journal of Immunology 2010 40 10 2667 2676 2-s2.0-77957108257 10.1002/eji.201040839
28. Martín-Gayo E., Sierra-Filardi E., Corbí A. L., Toribio M. L., Plasmacytoid dendritic cells resident in human thymus drive natural Treg cell development. Blood 2010 115 26 5366 5375 2-s2.0-77955896776 10.1182/blood-2009-10-248260
29. Hanabuchi S., Watanabe N., Wang Y.-H., Wang Y. H., Ito T., Shaw J., Cao W., Xiao-Feng Qin F., Liu Y.-J., Human plasmacytoid predendritic cells activate NK cells through glucocorticoid-induced tumor necrosis factor receptor-ligand (GITRL). Blood 2006 107 9 3617 3623 2-s2.0-33646387978 10.1182/blood-2005-08- 3419
30. Castellaneta A., Sumpter T. L., Chen L., Tokita D., Thomson A. W., NOD2 ligation subverts IFN- α production by liver plasmacytoid dendritic cells and inhibits their T cell allostimulatory activity via B7-H1 Up-regulation. Journal of Immunology 2009 183 11 6922 6932 2-s2.0-73349122911 10.4049/jimmunol.0900582
31. Baumgart D. C., Metzke D., Guckelberger O., Pascher A., Grötzinger C., Przesdzing I., Dörffel Y., Schmitz J., Thomas S., Aberrant plasmacytoid dendritic cell distribution and function in patients with Crohn's disease and ulcerative colitis. Clinical and Experimental Immunology 2011 166 1 46 54 2-s2.0-80052626409 10.1111/j.1365-2249.2011.04439.x
32. Baumgart D. C., Metzke D., Schmitz J., Scheffold A., Sturm A., Wiedenmann B., Dignass A. U., Patients with active inflammatory bowel disease lack immature peripheral blood plasmacytoid and myeloid dendritic cells. Gut 2005 54 2 228 236 2-s2.0-12344290269 10.1136/gut.2004.040360 (Pubitemid 40139239)
33. Wendland M., Czeloth N., Mach N., Malissen B., Kremmer E., Pabst O., Förster R., CCR9 is a homing receptor for plasmacytoid dendritic cells to the small intestine. Proceedings of the National Academy of Sciences of the United States of America 2007 104 15 6347 6352 2-s2.0-34547525608 10.1073/pnas.0609180104 (Pubitemid 47186097)
34. Hadeiba H., Sato T., Habtezion A., Oderup C., Pan J., Butcher E. C., CCR9 expression defines tolerogenic plasmacytoid dendritic cells able to suppress acute graft-versus-host disease. Nature Immunology 2008 9 11 1253 1260 2-s2.0-54549096767 10.1038/ni.1658
35. Mannon P. J., Leon F., Fuss I. J., Walter B. A., Begnami M., Quezado M., Yang Z., Yi C., Groden C., Friend J., Hornung R. L., Brown M., Gurprasad S., Kelsall B., Strober W., Successful granulocyte-colony stimulating factor treatment of Crohn's disease is associated with the appearance of circulating interleukin-10- producing T cells and increased lamina propria plasmacytoid dendritic cells. Clinical and Experimental Immunology 2009 155 3 447 456 2-s2.0-59249106936 10.1111/j.1365-2249.2008.03799.x
36. Pedersen A. E., Gad M., Kristensen N. N., Haase C., Nielsen C. H., Claesson M. H., Tolerogenic dendritic cells pulsed with enterobacterial extract suppress development of colitis in the severe combined immunodeficiency transfer model. Immunology 2007 121 4 526 532 2-s2.0-34447105220 10.1111/j.1365-2567. 2007.02600.x (Pubitemid 47030090)
37. - T cells. Journal of Immunology 2012 188 5 2164 2172 2-s2.0-84857493989 10.4049/jimmunol.1100559
38. Gonzalez-Rey E., Delgado M., Therapeutic treatment of experimental colitis with regulatory dendritic cells generated with vasoactive intestinal peptide. Gastroenterology 2006 131 6 1799 1811 2-s2.0-33845617286 10.1053/j.gastro.2006.10.023 (Pubitemid 44958527)
39. Sakuraba A., Sato T., Kamada N., Kitazume M., Sugita A., Hibi T., Th1/Th17 immune response is induced by mesenteric lymph node dendritic cells in crohn's disease. Gastroenterology 2009 137 5 1736 1745 2-s2.0-70350093623 10.1053/j.gastro.2009.07.049
40. Neurath M. F., Animal models of inflammatory bowel diseases: illuminating the pathogenesis of colitis, ileitis and cancer. Digestive Diseases 2012 30 supplement 1 91 94
41. Cabezon R., Ricart E., Espana C., Panes J., Benitez-Ribas D., Gram-negative enterobacteria induce tolerogenic maturation in dexamethasone conditioned dendritic cells. PLoS One 2012 7 e52456
42. Anderson A. E., Swan D. J., Sayers B. L., Harry R. A., Patterson A. M., Von Delwig A., Robinson J. H., Isaacs J. D., Hilkens C. M. U., LPS activation is required for migratory activity and antigen presentation by tolerogenic dendritic cells. Journal of Leukocyte Biology 2009 85 2 243 250 2-s2.0-59649123185 10.1189/jlb.0608374
43. Raïch-Regué D., Grau-López L., Naranjo-Gómez M., Ramo-Tello C., Pujol-Borrell R., Martínez-Cáceres E., Borràs F. E., Stable antigen-specific T-cell hyporesponsiveness induced by tolerogenic dendritic cells from multiple sclerosis patients. European Journal of Immunology 2012 42 3 771 782 2-s2.0-84859508662 10.1002/eji.201141835
44. Harry R. A., Anderson A. E., Isaacs J. D., Hilkens C. M., Generation and characterisation of therapeutic tolerogenic dendritic cells for rheumatoid arthritis. Annals of the Rheumatic Diseases 2010 69 11 2042 2050 2-s2.0-78149487035 10.1136/ard.2009.126383
45. Vermeire S., Rutgeerts P., Antibody responses in crohn's disease. Gastroenterology 2004 126 2 601 604 2-s2.0-0842300377 10.1053/j.gastro.2003.12. 020 (Pubitemid 38182317)
46. Hand T. W., Dos Santos L. M., Bouladoux N., Molloy M. J., Pagan A. J., Pepper M., Maynard C. L., Elson C. O., 3rd, Belkaid Y., Acute gastrointestinal infection induces long-lived microbiota-specific T cell responses. Science 2012 337 1553 1556 Science
47. Belkaid Y., Bouladoux N., Hand T. W., Effector and memory T cell responses to commensal bacteria. Trends in Immunology 2013 34 299 306